{{Rsnum
|rsid=4129148
|Gene=CSF2RA
|Chromosome=Y
|position=1029445
|Orientation=plus
|GMAF=0.4587
|Assembly=GRCh38
|GenomeBuild=38.1
|dbSNPBuild=141
|geno1=(C;C)
|geno2=(C;G)
|geno3=(G;G)
}}
{{ population diversity
| geno1=(C;C)
| geno2=(C;G)
| geno3=(G;G)
| CEU | 13.0 | 38.9 | 48.1
| HCB | 45.3 | 43.4 | 11.3
| JPT | 22.8 | 61.4 | 15.8
| YRI | 32.1 | 64.3 | 3.6
| ASW | 45.8 | 50.0 | 4.2
| CHB | 45.3 | 43.4 | 11.3
| CHD | 30.6 | 51.0 | 18.4
| GIH | 12.3 | 45.6 | 42.1
| LWK | 0.0 | 0.0 | 0.0
| MEX | 25.0 | 67.9 | 7.1
| MKK | 48.1 | 41.8 | 10.1
| TSI | 13.7 | 49.0 | 37.3
| HapMapRevision=28
}}
Located in the [[Pseudoautosomal region]]

[[rs4129148]], located near the [[CSF2RA]] gene, has been reported in a whole genome association study to be associated with [[schizophrenia]].

The risk allele (oriented to the dbSNP entry) is (G); the odds ratio associated with this allele is 3.23 (CI 2.04 - 5.15). {{PMID|17522711}}

{{GWAS Summary
|SNP=rs4129148
|PubMedID=17522711
|Condition=Schizophrenia
|Gene=CSF2RA,IL3RA
|Risk Allele=C
|pValue=4.00E-007
|OR=3.23
|95CI=2.04-5.15
}}

{{PMID Auto
|PMID=19197363
|Title=A genome-wide investigation of SNPs and CNVs in schizophrenia.
|OA=1
}}

{{PMID Auto
|PMID=19844207
|Title=Replication of association between schizophrenia and ZNF804A in the Irish Case-Control Study of Schizophrenia sample.
|OA=1
}}

{{PMID Auto
|PMID=20485477
|Title=New Genetic Findings in Schizophrenia: Is there Still Room for the Dopamine Hypothesis of Schizophrenia?
|OA=1
}}

{{GET Evidence
|impact=pathogenic
|qualified_impact=Insufficiently evaluated pathogenic
|inheritance=unknown
|quality_scores=Array
|dbsnp_id=rs4129148
|overall_frequency_n=43
|overall_frequency_d=102
|overall_frequency=0.421569
|n_genomes=8
|n_genomes_annotated=0
|n_haplomes=15
|n_articles=0
|n_articles_annotated=0
|in_gwas=Y
|autoscore=2
|webscore=N
}}

{{on chip | 23andMe v2}}
{{on chip | 23andMe v3}}
{{on chip | 23andMe v4}}
{{on chip | Affy GenomeWide 6}}
{{on chip | HumanOmni1Quad}}